High impact information on Adolescent Psychiatry

• Lithium in child and adolescent psychiatry [1].
• The psychostimulants methylphenidate, amphetamine and pemoline are among the most common medications used today in child and adolescent psychiatry for the treatment of patients with attention-deficit hyperactivity disorder [2].
• Child and adolescent psychiatry treatment programs may be a good setting for prevention efforts and treatment, which should focus on both nicotine dependence and psychiatric disorders [3].
• Psychopharmacology in child and adolescent psychiatry: a review of the past seven years. Part I [4].
• The psychostimulants methylphenidate, dextroamphetamine, and pemoline are among the most common medications used in child and adolescent psychiatry [5].

Biological context of Adolescent Psychiatry

• The current status of lithium therapy in child and adolescent psychiatry. A report of the Committee on Biological Aspects of Child Psychiatry of the American Academy of Child Psychiatry, December 1977 [6].

Associations of Adolescent Psychiatry with chemical compounds

• INTRODUCTION: Guanfacine hydrochloride is an alpha-2 adrenergic agonist, which has gained recent attention in the field of child and adolescent psychiatry [7].
• Fifty-seven trainees who had completed one of the 15 child and adolescent psychiatry placements in a Regional Health Authority, took part in a semi-structured telephone interview [8].

Gene context of Adolescent Psychiatry

• The psychostimulant dl-methylphenidate (MPH) remains the most common drug therapy in child and adolescent psychiatry for the treatment of attention-deficit-hyperactivity disorder (ADHD) [9].
• This study screened new adolescent psychiatric outpatients (n = 140) in the Department of Adolescent Psychiatry of the Hospital for Children and Adolescents, Helsinki, using immunoglobulin A antibody to tissue transglutaminase [10].
• Report of the Psychotherapy Task Force of the American Academy of Child and Adolescent Psychiatry [11].
• The author designed a curriculum for first-year (PGY-4) child and adolescent psychiatry residents with this perceived deficit in mind [12].
• CONCLUSION: Simple models of prediction of LOS in the field of child and adolescent psychiatry cannot be reliably based on empirical evidence [13].

References